LINC01116 has previously been found to be involved in two other cancer models: in the progression of glioblastoma (Brodie et al. 2017); and it is up-regulated in gefitinib resistant non-small cell lung cancer cells (Wang et al. 2020). The gene discussed is LINC01116; the disease is non-small cell lung carcinoma.